comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 18:34:58 - browse：255

Smartphone & medicine illustration — Alex Hogan/STAT

Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system.

In recent months, representatives of the Massachusetts state Medicaid program, MassHealth, have been presenting data suggesting reSET and reSET-O, Pear’s prescription apps that treat substance use disorder and opioid use disorder, saved the state money over a one-year period from 2021 to 2022. The data, which take into account health care utilization before and after people used the apps, have been presented to policymakers considering how to cover novel digital health products and shown to lawmakers considering federal legislation that would require Medicare coverage for prescription apps.

Pear, which filed for bankruptcy earlier this year, was one of the leading companies marketing prescription digital therapeutics, or Food and Drug Administration-cleared apps designed to treat disease. Pear’s reSET was the first such app cleared by the FDA in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： There’s a way to spot data fakery. All journals should be using it

Wikipedia

WSS

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Dewpoint Therapeutics lays off staff after losing partnerships

Think you might have Covid

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Caribou posts encouraging results on off

The surgeon had a dilemma only a Nazi medical text could resolve

entertainment

comprehensive

leisure time

How to save PrEP access — and even expand it

Parkinson’s finding may lead to tests and, someday, treatments

The cancer drug shortage isn’t new — and neither are the solutions

US jobless claims fall again as labor market continues to flash strength

As demand for Covid shots wanes, Moderna seeks its next success

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Continuity nursing helped my family in our darkest PICU moments

Stanford president’s abrupt resignation sparks debate

Heart attack and stroke risk calculators need revising

US jobless claims fall again as labor market continues to flash strength

focus

FDA clears AI tool for detecting skin cancer

Hormonal contraceptives don’t actually treat endometriosis

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

NIH director takes cautious approach to Biden drug pricing priority

Biotech venture capitalists face new demands from investors

Telehealth startups are trying to fill the menopause care vacuum

explore

Wikipedia

Wikipedia

Wikipedia